Remetinostat T16729
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Remetinostat is a hydroxamic acid-based inhibitor of histone deacetylase enzymes. It is under development for the treatment of cutaneous T-cell lymphoma.
CAS nr:
946150-57-8
Purity:
98%
Molecular Weight:
323,34
SMILES:
COC(=O)C1=CC=C(C=C1)OC(=O)CCCCCCC(=O)NO
Formula:
C16H21NO6
Pathway:
DNA Damage/DNA Repair,Chromatin/Epigenetic
Target:
HDAC,HDAC
